Herziening richtlijnen ‘Chronische nierschade’

Translated title of the contribution: Chronic kidney damage guidelines revision

Marc H Hemmelder, Jacintha van Balen, Nynke Scherpbier, Paul W Schenk, Mariska K Tuut, Ron T Gansevoort

Research output: Contribution to journalArticleAcademicpeer-review


Age has no effect on the diagnosis of 'chronic kidney damage'. Estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2 is to be considered 'abnormal' for patients of all ages. Albuminuria is classified as 'not abnormal', 'moderately elevated' and 'severely elevated'. Decreased eGFR and elevated albuminuria are independent risk factors for and predictors of cardiovascular and total mortality, progression of chronic kidney damage and end-stage kidney failure. Blood pressure target value is ≤ 130/80 mmHg. In case of an indication for blood pressure-lowering treatment for patients with chronic kidney damage and elevated albuminuria, an ACE inhibitor or angiotensin II receptor blocker is preferred. The general practitioner refers patients with chronic kidney damage and a highly elevated risk of mortality, cardiovascular disease, progression of kidney damage and end-stage kidney failure to the internist-nephrologist. Inform patients about drugs that can cause kidney damage and about the importance of dosage adjustments. When prescribing drugs to patients with eGFR < 50 ml/min per 1.73 m2, the pharmacist should, with the patient's approval, be informed of the eGFR.

Translated title of the contributionChronic kidney damage guidelines revision
Original languageDutch
Number of pages6
JournalNederlands Tijdschrift voor Geneeskunde
Publication statusPublished - 14-Jun-2018


Dive into the research topics of 'Chronic kidney damage guidelines revision'. Together they form a unique fingerprint.

Cite this